在人类癌症中对p53-调节的长非编码RNA的系统性表征揭示了不同瘤类型之间显著的异质性
Kausik Regunath1, Vitalay Fomin1, Zhaoqi Liu2
1Department of Biological Sciences, Columbia University, New York, New York.
Molecular cancer research : MCR
|February 23, 2024
概括
研究人员在各种癌症中确定了1000多个由p53蛋白调节的长非编码RNA (lncRNAs). 这些新的p53点显示了药物诱导和组织特异性模式,有助于癌症诊断和预后.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 蛋白质p53是一种关键的瘤抑制剂,在细胞压力下调节基因表达.
- 虽然p53在蛋白质编码基因中的作用已经确立,但其对长非编码RNA (lncRNA) 的调节及其与癌症相关性仍然不太清楚.
研究的目的:
- 为了识别全基因组的新型p53-target lncRNAs.
- 研究这些lncRNAs在癌症中的功能相关性,包括它们对化疗的反应及其预后价值.
主要方法:
- 在结肠癌细胞系和人类癌症患者数据集中全基因组识别lncRNAs.
- 通过激活p53.3的化疗剂诱导lncRNA的分析.
- 在五种癌症类型中,lncRNA表达与患者存活率的相关性.
主要成果:
- 确定了1000多个假定的p53点 lncRNAs,许多在正常组织中没有注释.
- 在p53调节的lncRNA中观察到显著的药物诱导和组织特异性.
- 证明特定的lncRNAs预测患者的生存,在不同类型的癌症中具有独特的模式.
结论:
- 这项研究扩大了已知的p53点,包括了大量的lncRNAs.
- 这些发现凸显了p53调节的lncRNAs在癌症中的显著异质性和临床相关性.
- 新发现的lncRNAs可以作为瘤诊断和预后的强大分类器.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:57piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:22MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
02:55The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
03:18Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K